Study on Laboratory Indicators Related to Lung Injury of Corona Virus Disease 2019

Clinical Laboratory
|January 25, 2021
PubMed

Insights

This study found that age and certain laboratory markers correlate with COVID-19 duration. Other markers indicate the severity of acute lung injury in coronavirus disease 2019 patients.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Clinical Medicine

Background:

  • The COVID-19 pandemic, caused by a novel coronavirus, has led to a global health crisis with no specific treatments.
  • Susceptibility is high due to a lack of pre-existing immunity.
  • The rapid spread necessitates understanding disease progression and severity indicators.

Purpose of the Study:

  • To investigate correlations between the time to negative RT-PCR results and laboratory indicators in COVID-19 patients.
  • To compare laboratory findings and RT-PCR negativity duration between patients with different oxygenation index levels, indicating varying degrees of acute lung injury.

Main Methods:

  • A retrospective study was conducted on 84 COVID-19 patients admitted between January 22 and February 25, 2020.
  • Patients were categorized into two groups based on their oxygenation index (≤300 mmHg vs. >300 mmHg).
  • Correlations between RT-PCR negative time, age, and various laboratory markers were analyzed.

Main Results:

  • A positive correlation was observed between RT-PCR negative time and age, white blood cell (WBC) count, lactate dehydrogenase (LDH), and serum creatinine (SCr).
  • Significant differences in fever duration, WBC count, lymphocyte count, C-reactive protein (CRP), liver enzymes (ALT, AST), albumin, LDH, SCr, D-dimer, and fibrinogen were found between the two oxygenation index groups.
  • These findings suggest distinct laboratory profiles associated with disease duration and acute lung injury severity.

Conclusions:

  • Age, WBC count, LDH, and SCr may influence the duration of COVID-19 viral shedding.
  • Indicators such as fever, WBC count, lymphocyte count, CRP, liver enzymes, albumin, LDH, SCr, D-dimer, and fibrinogen are associated with the severity of acute lung injury in COVID-19 patients.
  • These markers could aid in assessing prognosis and managing patients with coronavirus disease 2019.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
594
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
518
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
566
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
744
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
296
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.4K